ICD-10-CM Code C79.62

Secondary malignant neoplasm of left ovary

Version 2020 Billable Code Diagnoses For Females Only

Valid for Submission

C79.62 is a billable code used to specify a medical diagnosis of secondary malignant neoplasm of left ovary. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code C79.62 might also be used to specify conditions or terms like malignant tumor involving left ovary by direct extension from endometrium, malignant tumor involving left ovary by direct extension from fallopian tube, malignant tumor involving left ovary by direct extension from right ovary, malignant tumor involving left ovary by direct extension from uterine cervix, malignant tumor involving left ovary by direct extension from uterus, malignant tumor involving left ovary by direct extension from vagina, etc

The code C79.62 is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.

ICD-10:C79.62
Short Description:Secondary malignant neoplasm of left ovary
Long Description:Secondary malignant neoplasm of left ovary

Code Edits

The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:

  • Diagnoses for females only - Medicare Code Editor detects inconsistencies between a patient’s sex and any diagnosis on the patient’s record, this code applies to FEMALES only .

Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Malignant tumor involving left ovary by direct extension from endometrium
  • Malignant tumor involving left ovary by direct extension from fallopian tube
  • Malignant tumor involving left ovary by direct extension from right ovary
  • Malignant tumor involving left ovary by direct extension from uterine cervix
  • Malignant tumor involving left ovary by direct extension from uterus
  • Malignant tumor involving left ovary by direct extension from vagina
  • Malignant tumor involving left ovary by separate metastasis from endometrium
  • Malignant tumor involving left ovary by separate metastasis from fallopian tube
  • Malignant tumor involving left ovary by separate metastasis from right ovary
  • Malignant tumor involving left ovary by separate metastasis from uterine cervix
  • Malignant tumor involving left ovary by separate metastasis from vagina
  • Malignant tumor involving left ovary by separate metastasis uterus
  • Secondary malignant neoplasm of left ovary
  • Tumor involves both ovaries diffusely, primary tumor site cannot be determined

Diagnostic Related Groups

The ICD-10 code C79.62 is grouped in the following groups for version MS-DRG V37.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC).
applicable from 10/01/2019 through 09/30/2020.

  • 736 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC
  • 737 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC
  • 738 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC
  • 739 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC
  • 740 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC
  • 741 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC

Convert C79.62 to ICD-9

  • 198.6 - Second malig neo ovary (Approximate Flag)

Code Classification

  • Neoplasms (C00–D48)
    • Malignant neoplasms of ill-defined, other secondary and unspecified sites (C76-C80)
      • Secondary malignant neoplasm of other and unspecified sites (C79)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020

Information for Patients


Ovarian Cancer

The ovaries are part of the female reproductive system. They produce a woman's eggs and female hormones. Each ovary is about the size and shape of an almond.

Cancer of the ovary is not common, but it causes more deaths than other female reproductive cancers. The sooner ovarian cancer is found and treated, the better your chance for recovery. But ovarian cancer is hard to detect early. Women with ovarian cancer may have no symptoms or just mild symptoms until the disease is in an advanced stage. Then it is hard to treat. Symptoms may include

  • A heavy feeling in the pelvis
  • Pain in the lower abdomen
  • Bleeding from the vagina
  • Weight gain or loss
  • Abnormal periods
  • Unexplained back pain that gets worse
  • Gas, nausea, vomiting, or loss of appetite

To diagnose ovarian cancer, doctors do one or more tests. They include a physical exam, a pelvic exam, lab tests, ultrasound, or a biopsy. Treatment is usually surgery followed by chemotherapy.

NIH: National Cancer Institute


[Learn More]